Blog
RSS FeedPosted by Michael Wonder on 28 Mar 2020
EMA advises continued use of medicines for hypertension, heart or kidney disease during COVID-19 pandemic
27 March 2020 - EMA is aware of recent media reports and publications which question whether some medicines, for instance ...
Posted by Michael Wonder on 09 Mar 2020
Reports of epilepsy drug harm increase 30-fold since PHARMAC switches brands
7 March 2020 - Reports of people harmed while taking epilepsy drugs is 30 times what it was before PHARMAC ...
Posted by Michael Wonder on 25 Jan 2020
Bipolar disorder patients suffer 'terrible' side effects after PHARMAC drug brand switch
25 January 2020 - A woman with bipolar disorder says she was "crying everyday" and having thoughts of suicide after ...
Posted by Michael Wonder on 16 Jan 2020
Epilepsy deaths: level of risk in medication brand switch unclear, study says
17 January 2020 - Five deaths in people with epilepsy following a brand switch may be part of an under-represented level ...
Posted by Michael Wonder on 09 Jan 2020
PHARMAC epilepsy drug process questions
10 January 2020 - There are many unanswered questions about PHARMAC's decision to fund only one brand of the epilepsy ...
Posted by Michael Wonder on 08 Jan 2020
Abuses of FDA regulatory procedures - the case of Suboxone
8 January 2020 - The manufacturer of brand-name buprenorphine products exploited various FDA regulatory procedures to impede market entry of generic ...
Posted by Michael Wonder on 05 Jan 2020
'The public deserves to know why' - National intensifies calls for inquiry into PHARMAC after fifth death linked to epilepsy drug Logem
2 January 2020 - The National Party has intensified its call for a ministerial inquiry into PHARMAC's decision to switch ...
Posted by Michael Wonder on 04 Jan 2020
FDA’s deadline problem?
3 January 2020 - Rush to meet end-of-year drug-approval deadlines leads to more adverse effects, new study shows. ...
Posted by Michael Wonder on 17 Dec 2019
PHARMAC brand switch: man driving through Waterview Tunnel blacked out
18 December 2019 - An Auckland man had a seizure and blacked out as he drove through Auckland's Waterview Tunnel after ...
Posted by Michael Wonder on 17 Dec 2019
Calls for answers about PHARMAC delay after epilepsy deaths
17 December 2019 - The Opposition is calling for answers from the Government about why it took two weeks for ...
Posted by Michael Wonder on 16 Dec 2019
PHARMAC knew of epilepsy deaths for weeks but stayed silent
17 December 2019 - PHARMAC knew for more than two weeks that three deaths had been linked to its epilepsy ...
Posted by Michael Wonder on 11 Dec 2019
Six-year review shows success of the EU signal management system in improving safe use of medicines
11 December 2019 - In the first six years since the implementation of the 2012 EU pharmacovigilance legislation, the EU ...
Posted by Michael Wonder on 06 Dec 2019
PHARMAC says it welcomes a joint inquiry into four deaths - which have all been linked to the anti-epileptic drug, Logem
6 December 2019 - Chief Coroner Judge Deborah Marshall made the announcement today. ...
Posted by Michael Wonder on 05 Dec 2019
Epilepsy patients angry at being told symptoms all in their heads
5 December 2019 - PHARMAC funded research into whether people with epilepsy were imagining side effects from a medicine brand change ...
Posted by Michael Wonder on 05 Dec 2019
PHARMAC funded video downplays side effects of drug linked to four unexplained deaths, epilepsy patients say
5 December 2019 - Epilepsy patients are upset about a PHARMAC funded video which they say downplays the side effects of ...